MSL
PRAH

Mackay Shields LLC’s PRA Health Sciences, Inc. PRAH Stock Holding History

Mackay Shields LLC’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-90,810
Closed -$13.9M – 1488
2021
Q1 		$13.9M Sell
90,810
-90,987
-50% -$12.4M 0.1% 214
2020
Q4 		$22.8M Sell
181,797
-20,400
-10% -$2.28M 0.16% 146
2020
Q3 		$20.5M Buy
202,197
+46,710
+30% +$4.76M 0.14% 159
2020
Q2 		$15.1M Buy
155,487
+24,918
+19% +$2.32M 0.12% 188
2020
Q1 		$10.8M Sell
130,569
-56,410
-30% -$5.5M 0.1% 236
2019
Q4 		$20.8M Buy
186,979
+106,583
+133% +$11M 0.14% 173
2019
Q3 		$7.98M Sell
80,396
-98,567
-55% -$9.79M 0.05% 391
2019
Q2 		$17.7M Buy
178,963
+11,070
+7% +$1.06M 0.12% 192
2019
Q1 		$18.5M Buy
167,893
+14,088
+9% +$1.47M 0.13% 187
2018
Q4 		$14.1M Buy
153,805
+124,665
+428% +$12.6M 0.11% 223
2018
Q3 		$3.21M Buy
+29,140
New +$3.03M 0.02% 567
2018
Q2 		– Sell
-2,500
Closed -$207K – 1330
2018
Q1 		$207K Buy
+2,500
New +$222K ﹤0.01% 1215

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Mackay Shields LLC's PRAH Position: Q2 2021 in Review

Mackay Shields LLC sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 90,810 shares — an estimated $13.9M sold.

Mackay Shields LLC first reported a position in PRAH in Q1 2018 and held it in 12 quarters. The position peaked at $22.8M in Q4 2020. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Mackay Shields LLC reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 90,810 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $13.9M.
  • Mackay Shields LLC first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 12 quarters.
  • Mackay Shields LLC's PRA Health Sciences, Inc. position peaked at $22.8M in Q4 2020.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.